{"date":"2026-07-13","count":23,"source":"公開資訊觀測站（MOPS）","attribution":"引用請註明：Drugnews 事實帳本（https://drugnews.com.tw/filings/）與公開資訊觀測站原始公告","records":[{"id":"tw-6659-2026-07-13-1857-1t4i9o7","company_id":"6659","company":"天明製藥","market":"興櫃","industry":"生技醫療","date":"2026-07-13","time":"18:57:41","subject":"公告本公司現金股利配發基準日(更正事實發生日及公司決定日期)","clause":"第31款","fact_date":"2026-07-13","cite_as":"公開資訊觀測站重大訊息：天明製藥（6659），2026-07-13 18:57，「公告本公司現金股利配發基準日(更正事實發生日及公司決定日期)」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-6659-2026-07-13-1857-1mhr75l","company_id":"6659","company":"天明製藥","market":"興櫃","industry":"生技醫療","date":"2026-07-13","time":"18:57:15","subject":"公告本公司調整現金股利配息率(更正事實發生日)。","clause":"第31款","fact_date":"2026-07-13","cite_as":"公開資訊觀測站重大訊息：天明製藥（6659），2026-07-13 18:57，「公告本公司調整現金股利配息率(更正事實發生日)。」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-6659-2026-07-13-1826-1pdb8zk","company_id":"6659","company":"天明製藥","market":"興櫃","industry":"生技醫療","date":"2026-07-13","time":"18:26:35","subject":"公告本公司調整現金股利配息率。","clause":"第31款","fact_date":"2026-07-11","cite_as":"公開資訊觀測站重大訊息：天明製藥（6659），2026-07-13 18:26，「公告本公司調整現金股利配息率。」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-6659-2026-07-13-1826-141k8w6","company_id":"6659","company":"天明製藥","market":"興櫃","industry":"生技醫療","date":"2026-07-13","time":"18:26:05","subject":"公告本公司現金股利配發基準日","clause":"第31款","fact_date":"2026-07-11","cite_as":"公開資訊觀測站重大訊息：天明製藥（6659），2026-07-13 18:26，「公告本公司現金股利配發基準日」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-6547-2026-07-13-1806-qwt413","company_id":"6547","company":"高端疫苗","market":"上櫃","industry":"生技醫療","date":"2026-07-13","time":"18:06:47","subject":"本公司EV71疫苗於新加坡之查驗登記案，於行政預審階段申請主動撤回以進行資料補件","clause":"第10款","fact_date":"2026-07-13","cite_as":"公開資訊觀測站重大訊息：高端疫苗（6547），2026-07-13 18:06，「本公司EV71疫苗於新加坡之查驗登記案，於行政預審階段申請主動撤回以進行資料補件」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-6589-2026-07-13-1801-fw040o","company_id":"6589","company":"台康生技","market":"上市","industry":"生技醫療","date":"2026-07-13","time":"18:01:56","subject":"本公司股份買回計畫執行完畢","clause":"第35款","fact_date":"2026-07-13","cite_as":"公開資訊觀測站重大訊息：台康生技（6589），2026-07-13 18:01，「本公司股份買回計畫執行完畢」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-4163-2026-07-13-1726-54swv6","company_id":"4163","company":"鐿鈦","market":"上櫃","industry":"生技醫療","date":"2026-07-13","time":"17:26:10","subject":"公告本公司法人董事改派代表人","clause":"第6款","fact_date":"2026-07-13","cite_as":"公開資訊觀測站重大訊息：鐿鈦（4163），2026-07-13 17:26，「公告本公司法人董事改派代表人」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-7561-2026-07-13-1702-n8a70s","company_id":"7561","company":"光晟生技","market":"興櫃","industry":"生技醫療","date":"2026-07-13","time":"17:02:39","subject":"公告本公司董事會通過第一屆永續發展委員會委員","clause":"第6款","fact_date":"2026-07-13","cite_as":"公開資訊觀測站重大訊息：光晟生技（7561），2026-07-13 17:02，「公告本公司董事會通過第一屆永續發展委員會委員」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-7561-2026-07-13-1702-bkom30","company_id":"7561","company":"光晟生技","market":"興櫃","industry":"生技醫療","date":"2026-07-13","time":"17:02:17","subject":"公告本公司董事會決議現金股利除息基準日及發放日","clause":"第31款","fact_date":"2026-07-13","cite_as":"公開資訊觀測站重大訊息：光晟生技（7561），2026-07-13 17:02，「公告本公司董事會決議現金股利除息基準日及發放日」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-7561-2026-07-13-1701-1xjigku","company_id":"7561","company":"光晟生技","market":"興櫃","industry":"生技醫療","date":"2026-07-13","time":"17:01:55","subject":"公告本公司董事會通過內部稽核主管案","clause":"第11款","fact_date":"2026-07-13","cite_as":"公開資訊觀測站重大訊息：光晟生技（7561），2026-07-13 17:01，「公告本公司董事會通過內部稽核主管案」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-7561-2026-07-13-1701-3g7pnl","company_id":"7561","company":"光晟生技","market":"興櫃","industry":"生技醫療","date":"2026-07-13","time":"17:01:31","subject":"公告本公司董事會通過財務及會計主管案","clause":"第11款","fact_date":"2026-07-13","cite_as":"公開資訊觀測站重大訊息：光晟生技（7561），2026-07-13 17:01，「公告本公司董事會通過財務及會計主管案」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-7561-2026-07-13-1701-q6yux6","company_id":"7561","company":"光晟生技","market":"興櫃","industry":"生技醫療","date":"2026-07-13","time":"17:01:01","subject":"公告本公司董事會通過發言人案","clause":"第11款","fact_date":"2026-07-13","cite_as":"公開資訊觀測站重大訊息：光晟生技（7561），2026-07-13 17:01，「公告本公司董事會通過發言人案」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-7561-2026-07-13-1700-i8tame","company_id":"7561","company":"光晟生技","market":"興櫃","industry":"生技醫療","date":"2026-07-13","time":"17:00:14","subject":"公告本公司董事會通過總經理任命案","clause":"第6款","fact_date":"2026-07-13","cite_as":"公開資訊觀測站重大訊息：光晟生技（7561），2026-07-13 17:00，「公告本公司董事會通過總經理任命案」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-1786-2026-07-13-1651-tz1c4o","company_id":"1786","company":"科妍","market":"上市","industry":"生技醫療","date":"2026-07-13","time":"16:51:00","subject":"公告本公司第四次庫藏股買回期間屆滿執行情形","clause":"第35款","fact_date":"2026-07-13","cite_as":"公開資訊觀測站重大訊息：科妍（1786），2026-07-13 16:51，「公告本公司第四次庫藏股買回期間屆滿執行情形」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-4167-2026-07-13-1636-y64mo4","company_id":"4167","company":"松瑞藥","market":"上櫃","industry":"生技醫療","date":"2026-07-13","time":"16:36:24","subject":"公告本公司訂定除權息基準日及相關事宜","clause":"第14款","fact_date":"2026-07-13","cite_as":"公開資訊觀測站重大訊息：松瑞藥（4167），2026-07-13 16:36，「公告本公司訂定除權息基準日及相關事宜」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-4167-2026-07-13-1631-isqttc","company_id":"4167","company":"松瑞藥","market":"上櫃","industry":"生技醫療","date":"2026-07-13","time":"16:31:50","subject":"公告本公司董事會重要決議事項","clause":"第53款","fact_date":"2026-07-13","cite_as":"公開資訊觀測站重大訊息：松瑞藥（4167），2026-07-13 16:31，「公告本公司董事會重要決議事項」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-4155-2026-07-13-1614-41qa3w","company_id":"4155","company":"訊映","market":"上市","industry":"生技醫療","date":"2026-07-13","time":"16:14:51","subject":"(更正)公告本公司買回庫藏股已執行完畢","clause":"第35款","fact_date":"2026-07-09","cite_as":"公開資訊觀測站重大訊息：訊映（4155），2026-07-13 16:14，「(更正)公告本公司買回庫藏股已執行完畢」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-6748-2026-07-13-1541-mqmb1a","company_id":"6748","company":"亞果生醫","market":"興櫃","industry":"生技醫療","date":"2026-07-13","time":"15:41:52","subject":"公告擬與科科生醫(星醫美學集團)簽訂總代理合約","clause":"第8款","fact_date":"2026-07-13","cite_as":"公開資訊觀測站重大訊息：亞果生醫（6748），2026-07-13 15:41，「公告擬與科科生醫(星醫美學集團)簽訂總代理合約」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-3716-2026-07-13-1503-p67uuk","company_id":"3716","company":"中化控股","market":"上市","industry":"生技醫療","date":"2026-07-13","time":"15:03:43","subject":"公告本公司內部稽核主管異動","clause":"第8款","fact_date":"2026-07-13","cite_as":"公開資訊觀測站重大訊息：中化控股（3716），2026-07-13 15:03，「公告本公司內部稽核主管異動」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-4190-2026-07-13-1454-mn0adl","company_id":"4190","company":"佐登-KY","market":"上市","industry":"生技醫療","date":"2026-07-13","time":"14:54:12","subject":"公告本公司中華民國境內第三次有擔保轉換公司債(佐登三)因颱風停止營業致賣回權行使順延事宜","clause":"第51款","fact_date":"2026-07-13","cite_as":"公開資訊觀測站重大訊息：佐登-KY（4190），2026-07-13 14:54，「公告本公司中華民國境內第三次有擔保轉換公司債(佐登三)因颱風停止營業致賣回權行使順延事宜」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-6492-2026-07-13-1411-12r70x3","company_id":"6492","company":"生華科","market":"上櫃","industry":"生技醫療","date":"2026-07-13","time":"14:11:49","subject":"公告本公司現金增資發行新股認股基準日等相關事宜","clause":"第11款","fact_date":"2026-07-13","cite_as":"公開資訊觀測站重大訊息：生華科（6492），2026-07-13 14:11，「公告本公司現金增資發行新股認股基準日等相關事宜」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-1720-2026-07-13-1139-6zp9x4","company_id":"1720","company":"生達","market":"上市","industry":"生技醫療","date":"2026-07-13","time":"11:39:39","subject":"澄清媒體有關本公司報導","clause":"第51款","fact_date":"2026-07-13","cite_as":"公開資訊觀測站重大訊息：生達（1720），2026-07-13 11:39，「澄清媒體有關本公司報導」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-6875-2026-07-13-0626-amx40c","company_id":"6875","company":"國邑*","market":"上櫃","industry":"生技醫療","date":"2026-07-13","time":"06:26:09","subject":"本公司合作夥伴Liquidia已向中國大陸國家藥品監督管理局(NMPA)遞交吸入新藥L606(微脂體-曲前列環素) IND用於治療PH-ILD 的全球第三期臨床試驗申請(代號：Re-Spire)","clause":"第53款","fact_date":"2026-07-10","cite_as":"公開資訊觀測站重大訊息：國邑*（6875），2026-07-13 06:26，「本公司合作夥伴Liquidia已向中國大陸國家藥品監督管理局(NMPA)遞交吸入新藥L606(微脂體-曲前列環素) IN」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"}]}